Researchers sought to characterize the prevalence and clinical features of individuals with both MS and INO in a population-based cohort of patients with MS.
Researchers sought to assess the change in blood pressure in patients with MS treated with ATZ and prior HDMP treatment compared with patients receiving HDMP only for acute relapse.
For individuals with MS and cancer, breast cancers are less likely to be detected through screening and colorectal cancer is more likely to be detected at an early stage.
Using data from the Ultimate I and II phase 3 trials, researchers conducted a post-hoc analysis to study the effects of ublituximab on disease activity in relapsing multiple sclerosis.
Presenting at the 2022 AAN Annual Meeting, researchers assessed the neuropsychological profile of pediatric MS and its association with resting-state functional connectivity abnormalities in cognitive and motor networks.